Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
Jun Liu(Sichuan University), Jennifer L. Harris(Genomics Institute of the Novartis Research Foundation), Colleen Kowal(Novartis Foundation), Lilli Petruzzelli(Novartis (Switzerland)), Cheng Dai(Huazhong Agricultural University), Chun Li(University of Southern California), Martin P. Graham(University of Michigan), Auzon Steffy(Genomics Institute of the Novartis Research Foundation), Mindy H. Hsieh(Genomics Institute of the Novartis Research Foundation), Shifeng Pan(Genomics Institute of the Novartis Research Foundation), William R. Sellers(Broad Institute), Peter G. Schultz(Scripps Research Institute), Nicholas Ng(Genomics Institute of the Novartis Research Foundation), Thomas E. Carey(University of Michigan), Maria Cristina Villarroel(Novartis (Switzerland)), Jianwei Che(Genomics Institute of the Novartis Research Foundation), Gui-Rong Guo(Genomics Institute of the Novartis Research Foundation), Shailaja Kasibhatla(Genomics Institute of the Novartis Research Foundation), H. Martin Seidel(Genomics Institute of the Novartis Research Foundation), Xu Wu(Massachusetts General Hospital), Shannon Flynn(University of Michigan), J. Chad Brenner(University of Michigan), Van Phung(Genomics Institute of the Novartis Research Foundation), Allen G. Li(Genomics Institute of the Novartis Research Foundation), Gary Vanasse(Novartis (Switzerland)), Jie Li(Weifang Medical University), Tao Wang(Pfizer (United States)), Yan Wang(Shengli Oilfield Central Hospital), Jane Cheng(Beth Israel Deaconess Medical Center), Fangxian Sun(Genomics Institute of the Novartis Research Foundation), Anthony Boral(Novartis (Switzerland)), Peter McNamara(Genomics Institute of the Novartis Research Foundation), Margaret E. McLaughlin(Novartis (Switzerland)), Alwin G. Schuller(AstraZeneca (United States)), AnneMarie Pferdekamper(Genomics Institute of the Novartis Research Foundation), Celin Tompkins(Genomics Institute of the Novartis Research Foundation)
Cited by 833
Related Papers
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
Organization of 'nanocrystal molecules' using DNA
|Nature|1996|3k
Gene expression correlates of clinical prostate cancer behavior
|Cancer Cell|2002|2.5k
Restoration of p53 function leads to tumour regression in vivo
|Nature|2007|1.8k